| Stage | SOLS | % of rev | ACNT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.0B | 100.00% | $27M | 100.00% | SOLS ×38.55 |
| Gross profit | $345M | 32.98% | $7M | 26.24% | SOLS +6.7pp |
| Operating income | $164M | 15.68% | $2M | 6.04% | SOLS +9.6pp |
| Pre-tax income | $112M | 10.71% | $2M | 6.99% | SOLS +3.7pp |
| Net income | $88M | 8.41% | $1M | 5.17% | SOLS +3.2pp |
| Stage | SOLS | ACNT | Gap · A − B |
|---|---|---|---|
| Revenue | $1.0B100.00% | $27M100.00% | SOLS ×38.55 |
| Gross profit | 32.98%$345M | 26.24%$7M | SOLS +6.7pp |
| Operating income | 15.68%$164M | 6.04%$2M | SOLS +9.6pp |
| Pre-tax income | 10.71%$112M | 6.99%$2M | SOLS +3.7pp |
| Net income |
| 8.41%$88M |
| 5.17%$1M |
| SOLS +3.2pp |
No shared counterparties.